文献速递血栓与止血

炎症在静脉血栓形成与溶解中的作用

Role of inflammation in venous thrombosis formation and resolution.
PubMed 文献 · J Thromb Haemost · 2026-03-30

本文综述静脉血栓栓塞症(VTE)中炎症机制的作用,涵盖损伤相关分子模式、细胞因子和趋化因子促进免疫细胞募集的过程。重点讨论单核细胞表型在VTE不同阶段的关键作用及其作为抗凝之外治疗策略的潜力,并探讨对长期并发症预防的意义。

要点

  • VTE中损伤相关分子模式、细胞因子和趋化因子促进免疫细胞募集。
  • 单核细胞表型在VTE不同阶段发挥重要作用,可能成为抗凝外的治疗靶点。
  • 炎症机制可能影响血栓后综合征和肺栓塞后综合征的预防。

核心结论

  • 炎症通过损伤相关分子模式、细胞因子和趋化因子促进免疫细胞募集,参与VTE血栓形成与溶解。
  • 单核细胞表型在VTE不同阶段发挥主要作用,调控这些细胞可能成为抗凝之外的治療策略。
  • 炎症机制对预防或减少血栓后综合征和肺栓塞后综合征等长期并发症具有关键意义。

研究设计与样本

  • 本文为综述,总结炎症在静脉血栓形成与溶解中的作用及相关细胞机制。

主要发现

  • VTE与多种损伤相关分子模式、细胞因子和趋化因子的生成相关,促进免疫细胞募集。
  • 单核细胞表型在VTE不同阶段发挥主要作用。
  • 参与VTE的不同细胞类型在疾病状态下可能相互影响。

临床怎么用

  • 抗凝剂是VTE治疗基石,确诊后应使用以预防早期致命性和非致命性复发。
  • 调控单核细胞等炎症细胞可能成为抗凝之外的有前景治疗策略。
  • 未来需阐明VTE中炎症的调控方式,以提出改善治疗管理和患者结局的新策略。

局限性

  • 尽管治疗进步,VTE长期预后仍差,且抗凝治疗增加出血风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Venous thromboembolism (VTE) is a frequent disease associated with high mortality in case of pulmonary embolism and long-term complications that dramatically affect patient quality of life. Anticoagulants are the cornerstone of treatment and should be administered once VTE has been diagnosed to prevent early fatal and nonfatal recurrences. However, despite therapeutic advances, the long-term prognosis of VTE remains poor and is associated with increased bleeding risk due to the anticoagulant treatment. Studies have established that VTE is associated with the generation of a wide range of damage-associated molecular patterns, cytokines, and chemokines, promoting the recruitment of immune cells. This review summarized how these cells contribute to thrombus formation and resolution. We also discussed how the different cell types involved in VTE might interact with each other in these disease settings. We highlighted a major role of monocyte phenotypes in the different phases of VTE and how manipulating these cells might represent an interesting therapeutic strategy in addition to the anticoagulants. Finally, we discussed the critical implications these mechanisms might have in preventing or reducing the occurrence of long-term complications, including postthrombotic and postpulmonary embolism syndromes. Future directions should consider deciphering how inflammation is regulated in VTE to propose new therapeutic strategies to improve therapeutic management and patient outcomes.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Le Mac J, Ly MB, Lemarié CA, et al. Role of inflammation in venous thrombosis formation and resolution. J Thromb Haemost. 2026. PMID: 41921861. doi:10.1016/j.jtha.2026.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。